CD81 通过阻断 CD274/PD-L1 的选择性自噬降解驱动放射抵抗性胶质母细胞瘤的免疫逃逸
CD81 drives immune evasion in radioresistant glioblastoma by blocking selective autophagic degradation of CD274/PD-L1.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Emerging roles of mesenchymal stem cell-derived exosomes in gastrointestinal cancers.
Emerging roles of mesenchymal stem cell-derived exosomes in gastrointestinal cancers.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
胃肠道肿瘤是最常见的实体肿瘤,预后差,仍是癌症治疗中的主要挑战。间充质干细胞(MSC)是具有分化为多种细胞类型潜能的多能基质细胞。多项研究表明,MSC来源的外泌体已成为多种生理和病理过程中细胞间通讯的重要调节因子。值得注意的是,MSC来源的外泌体通过递送蛋白质、RNA、DNA和生物活性脂质,在不同癌症中支持或抑制肿瘤进展。本文总结了MSC来源的外泌体在癌症研究中的当前进展,特别提及其在胃肠道肿瘤发展中的作用。MSC来源的外泌体有望成为治疗胃肠道癌症的一种新的潜在策略。
Gastrointestinal tumours are the most common solid tumours, with a poor prognosis and remain a major challenge in cancer treatment. Mesenchymal stem cells (MSC) are multipotent stromal cells with the potential to differentiate into multiple cell types. Several studies have shown that MSC-derived exosomes have become essential regulators of intercellular communication in a variety of physiological and pathological processes.
Notably, MSC-derived exosomes support or inhibit tumour progression in different cancers through the delivery of proteins, RNA, DNA, and bioactive lipids.
Herein, we summarise current advances in MSC-derived exosomes in cancer research, with particular reference to their role in gastrointestinal tumour development. MSC-derived exosomes are expected to be a novel potential strategy for the treatment of gastrointestinal cancers.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。